{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:49:12Z","timestamp":1792442952730,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017656","name":"Gordon and Marilyn Macklin Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","jpeds.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jpeds.2025.114479","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:33:59Z","timestamp":1737707639000},"page":"114479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cyclosporine Treatment in Patients with Kawasaki Disease and Coronary Artery Aneurysms or Treatment Resistance"],"prefix":"10.1016","volume":"279","author":[{"given":"Irene","family":"Bellicini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelia","family":"Bainto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-175X","authenticated-orcid":false,"given":"Adriana H.","family":"Tremoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2025.114479_bib1","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","article-title":"Kawasaki disease","volume":"67","author":"Newburger","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2025.114479_bib2","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2025.114479_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng.2007.59","article-title":"ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms","volume":"40","author":"Onouchi","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jpeds.2025.114479_bib4","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/hmg\/ddq176","article-title":"Common variants in CASP3 confer susceptibility to Kawasaki disease","volume":"19","author":"Onouchi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpeds.2025.114479_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/tpj.2011.45","article-title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease","volume":"13","author":"Onouchi","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jpeds.2025.114479_bib6","series-title":"StatPearls","article-title":"Kawasaki Disease","author":"Modesti","year":"2024"},{"key":"10.1016\/j.jpeds.2025.114479_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/pr.2015.12","article-title":"Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease","volume":"77","author":"Wakiguchi","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2025.114479_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145486","article-title":"Variations in ORAI1 gene associated with Kawasaki disease","volume":"11","author":"Onouchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2025.114479_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.humpath.2012.05.004","article-title":"The role of TGF-\u03b2 and myofibroblasts in the arteritis of Kawasaki disease","volume":"44","author":"Shimizu","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jpeds.2025.114479_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1756-185X.13207","article-title":"Histopathological aspects of cardiovascular lesions in Kawasaki disease","volume":"21","author":"Takahashi","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jpeds.2025.114479_bib11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/323155","article-title":"CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease","volume":"184","author":"Brown","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2025.114479_bib12","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1038\/s41598-020-61667-y","article-title":"The role of Ca2+\/NFAT in dysfunction and inflammation of human coronary endothelial cells induced by sera from patients with Kawasaki disease","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpeds.2025.114479_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1186\/s12864-015-2323-5","article-title":"The transcriptional profile of coronary arteritis in Kawasaki disease","volume":"16","author":"Rowley","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jpeds.2025.114479_bib14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s40262-018-0653-6","article-title":"Infliximab pharmacokinetics are influenced by intravenous immunoglobulin administration in patients with Kawasaki disease","volume":"57","author":"Vande Casteele","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2025.114479_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/archdischild-2023-325639","article-title":"Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis","volume":"108","author":"Miyata","year":"2023","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2025.114479_bib16","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","article-title":"Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association","volume":"150","author":"Jone","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2025.114479_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpeds.2012.02.048","article-title":"Calcineurin inhibitor treatment of intravenous immunoglobulin\u2013resistant Kawasaki disease","volume":"161","author":"Tremoulet","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2025.114479_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0140-6736(18)32003-8","article-title":"Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised cont","volume":"393","author":"Hamada","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2025.114479_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/INF.0b013e318220c3cf","article-title":"Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin","volume":"30","author":"Suzuki","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2025.114479_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15280","article-title":"Continuous cyclosporine a infusion in patients with severe Kawasaki disease","volume":"64","author":"Seki","year":"2022","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2025.114479_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ped.12778","article-title":"Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant","volume":"58","author":"Okada","year":"2016","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2025.114479_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15673","article-title":"Length of hospital stay with prednisolone or cyclosporine for Kawasaki disease","volume":"65","author":"Watanabe","year":"2023","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2025.114479_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15658","article-title":"Prednisolone versus cyclosporine as initial treatment for Kawasaki disease","volume":"65","author":"Kameda","year":"2023","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2025.114479_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1321533","article-title":"Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment","volume":"11","author":"Murayama","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jpeds.2025.114479_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1089-3261(05)70278-6","article-title":"Cyclosporine and tacrolimus: the mainstay of immunosuppressive therapy for solid organ transplantation","volume":"1","author":"Testa","year":"1997","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jpeds.2025.114479_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10384-021-00878-w","article-title":"Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt-Koyanagi-Harada disease","volume":"66","author":"Ono","year":"2022","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jpeds.2025.114479_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15549","article-title":"Kawasaki disease and staphylococcus aureus bacteremia under cyclosporine therapy","volume":"65","author":"Nishiyama","year":"2023","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2025.114479_bib28","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00467-009-1264-0","article-title":"Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome","volume":"24","author":"Hamasaki","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpeds.2025.114479_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.5732\/cjc.011.10071","article-title":"Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen","volume":"30","author":"Chen","year":"2011","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.jpeds.2025.114479_bib30","article-title":"Cardiovascular involvement in Epstein-Barr virus infection","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpeds.2025.114479_bib31","first-page":"183","article-title":"Posterior reversible encephalopathy syndrome (PRES): diagnosis and management","volume":"22","author":"Triplett","year":"2022","journal-title":"Pract Neurol"},{"key":"10.1016\/j.jpeds.2025.114479_bib32","article-title":"Frequency and risk factors of cyclosporine-induced neurotoxicity in allogeneic stem cell transplant recipients","volume":"13","author":"Danish","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jpeds.2025.114479_bib33","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2174\/0929867327666201006153202","article-title":"Chemistry and toxicity - a review","volume":"28","author":"Patocka","year":"2021","journal-title":"Curr Med Chem"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347625000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347625000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T21:02:41Z","timestamp":1741640561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347625000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"alternative-id":["S0022347625000198"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2025.114479","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine Treatment in Patients with Kawasaki Disease and Coronary Artery Aneurysms or Treatment Resistance","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2025.114479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114479"}}